Literature DB >> 32667714

Indole/isatin-containing hybrids as potential antibacterial agents.

Feng Song1,2, Zhenghua Li1, Yunqiang Bian1, Xiankai Huo3, Junman Fang2, Linlin Shao2, Meng Zhou2.   

Abstract

The emergence and worldwide spread of drug-resistant bacteria have already posed a serious threat to human life, creating the urgent need to develop potent and novel antibacterial drug candidates with high efficacy. Indole and isatin (indole-2,3-dione) present a wide structural and mechanistic diversity, so their derivatives possess various pharmacological properties and occupy a salient place in the development of new drugs. Indole/isatin-containing hybrids, which demonstrate a promising activity against a panel of clinically important Gram-positive and Gram-negative bacteria, are privileged scaffolds for the discovery of novel antibacterial candidates. This review, covering articles published between January 2015 and May 2020, focuses on the development and structure-activity relationship (SAR) of indole/isatin-containing hybrids with potential application for fighting bacterial infections, to facilitate further rational design of novel drug candidates.
© 2020 Deutsche Pharmazeutische Gesellschaft.

Entities:  

Keywords:  antibacterial; drug resistance; hybrid compounds; indole; isatin; structure-activity relationship

Mesh:

Substances:

Year:  2020        PMID: 32667714     DOI: 10.1002/ardp.202000143

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  2 in total

1.  Hyperbranched Polyesters Based on Indole- and Lignin-Derived Monomeric Aromatic Aldehydes as Effective Nonionic Antimicrobial Coatings with Excellent Biocompatibility.

Authors:  Xiaoya Li; Xiao Wang; Sathiyaraj Subramaniyan; Yang Liu; Jingyi Rao; Baozhong Zhang
Journal:  Biomacromolecules       Date:  2021-12-21       Impact factor: 6.988

2.  Synthesis and diverse biological activity profile of triethylammonium isatin-3-hydrazones.

Authors:  Andrei Bogdanov; Olga Tsivileva; Alexandra Voloshina; Anna Lyubina; Syumbelya Amerhanova; Ekaterina Burtceva; Sergey Bukharov; Alexander Samorodov; Valentin Pavlov
Journal:  ADMET DMPK       Date:  2022-01-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.